Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Agraflora Organics International Inc stock logo
AGRA
Agraflora Organics International
$0.00
$0.00
$0.00
N/AN/AN/A580,821 shs
ATT
Abattis Bioceuticals
C$0.00
C$0.05
C$0.74
N/AN/A1.42 million shsN/A
Neuralstem, Inc. stock logo
CUR
Neuralstem
$1.87
-2.1%
$1.06
$1.10
$13.78
$3.93M1.81236,278 shs1.84 million shs
ePlus inc. stock logo
PLUS
ePlus
$87.15
+1.8%
$79.61
$62.11
$93.98
$2.26B1.04163,111 shs134,532 shs
7 Stocks to Buy And Hold Forever Cover

Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Agraflora Organics International Inc stock logo
AGRA
Agraflora Organics International
0.00%0.00%0.00%0.00%0.00%
ATT
Abattis Bioceuticals
0.00%0.00%0.00%0.00%0.00%
Neuralstem, Inc. stock logo
CUR
Neuralstem
0.00%0.00%-1.06%+16.15%+135.99%
ePlus inc. stock logo
PLUS
ePlus
0.00%+1.02%+10.36%+0.24%+33.39%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Agraflora Organics International Inc stock logo
AGRA
Agraflora Organics International
$0.00
$0.00
$0.00
N/AN/AN/A580,821 shs
ATT
Abattis Bioceuticals
C$0.00
C$0.05
C$0.74
N/AN/A1.42 million shsN/A
Neuralstem, Inc. stock logo
CUR
Neuralstem
$1.87
-2.1%
$1.06
$1.10
$13.78
$3.93M1.81236,278 shs1.84 million shs
ePlus inc. stock logo
PLUS
ePlus
$87.15
+1.8%
$79.61
$62.11
$93.98
$2.26B1.04163,111 shs134,532 shs
7 Stocks to Buy And Hold Forever Cover

Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Agraflora Organics International Inc stock logo
AGRA
Agraflora Organics International
0.00%0.00%0.00%0.00%0.00%
ATT
Abattis Bioceuticals
0.00%0.00%0.00%0.00%0.00%
Neuralstem, Inc. stock logo
CUR
Neuralstem
0.00%0.00%-1.06%+16.15%+135.99%
ePlus inc. stock logo
PLUS
ePlus
0.00%+1.02%+10.36%+0.24%+33.39%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Agraflora Organics International Inc stock logo
AGRA
Agraflora Organics International
0.00
N/AN/AN/A
ATT
Abattis Bioceuticals
0.00
N/AN/AN/A
Neuralstem, Inc. stock logo
CUR
Neuralstem
0.00
N/AN/AN/A
ePlus inc. stock logo
PLUS
ePlus
3.00
BuyN/AN/A

Current Analyst Ratings Breakdown

Latest PLUS, CUR, ATT, and AGRA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/13/2026
ePlus inc. stock logo
PLUS
ePlus
DowngradeBuy (B-)Hold (C+)
4/6/2026
ePlus inc. stock logo
PLUS
ePlus
UpgradeHoldStrong-Buy
3/27/2026
ePlus inc. stock logo
PLUS
ePlus
UpgradeHold (C+)Buy (B-)
3/10/2026
ePlus inc. stock logo
PLUS
ePlus
DowngradeBuy (B-)Hold (C+)
2/20/2026
ePlus inc. stock logo
PLUS
ePlus
UpgradeHold (C+)Buy (B-)
(Data available from 5/5/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Agraflora Organics International Inc stock logo
AGRA
Agraflora Organics International
N/AN/AN/AN/AN/AN/A
ATT
Abattis Bioceuticals
N/AN/AN/AN/AN/AN/A
Neuralstem, Inc. stock logo
CUR
Neuralstem
$260K15.10N/AN/A$6.64 per share0.28
ePlus inc. stock logo
PLUS
ePlus
$2.07B1.11$5.26 per share16.56$36.73 per share2.37
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Agraflora Organics International Inc stock logo
AGRA
Agraflora Organics International
N/AN/AN/AN/AN/AN/AN/AN/AN/A
ATT
Abattis Bioceuticals
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Neuralstem, Inc. stock logo
CUR
Neuralstem
-$4.93MN/AN/AN/AN/A-39,417.64%-170.51%-110.16%N/A
ePlus inc. stock logo
PLUS
ePlus
$107.98M$5.0317.3317.090.935.63%12.06%6.80%5/28/2026 (Estimated)

Latest PLUS, CUR, ATT, and AGRA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/28/2026Q4 2026
ePlus inc. stock logo
PLUS
ePlus
$0.98N/AN/AN/A$569.25 millionN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Agraflora Organics International Inc stock logo
AGRA
Agraflora Organics International
N/AN/AN/AN/AN/A
ATT
Abattis Bioceuticals
N/AN/AN/AN/AN/A
Neuralstem, Inc. stock logo
CUR
Neuralstem
N/AN/AN/AN/AN/A
ePlus inc. stock logo
PLUS
ePlus
$1.001.15%N/A19.88%N/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Agraflora Organics International Inc stock logo
AGRA
Agraflora Organics International
N/AN/AN/A
ATT
Abattis Bioceuticals
N/AN/AN/A
Neuralstem, Inc. stock logo
CUR
Neuralstem
N/A
2.53
2.53
ePlus inc. stock logo
PLUS
ePlus
N/A
2.13
1.78

Institutional Ownership

CompanyInstitutional Ownership
Agraflora Organics International Inc stock logo
AGRA
Agraflora Organics International
N/A
ATT
Abattis Bioceuticals
N/A
Neuralstem, Inc. stock logo
CUR
Neuralstem
38.30%
ePlus inc. stock logo
PLUS
ePlus
93.80%

Insider Ownership

CompanyInsider Ownership
Agraflora Organics International Inc stock logo
AGRA
Agraflora Organics International
N/A
ATT
Abattis Bioceuticals
N/A
Neuralstem, Inc. stock logo
CUR
Neuralstem
5.38%
ePlus inc. stock logo
PLUS
ePlus
1.93%
CompanyEmployeesShares OutstandingFree FloatOptionable
Agraflora Organics International Inc stock logo
AGRA
Agraflora Organics International
N/AN/AN/ANot Optionable
ATT
Abattis Bioceuticals
N/AN/AN/ANot Optionable
Neuralstem, Inc. stock logo
CUR
Neuralstem
62.10 millionN/ANot Optionable
ePlus inc. stock logo
PLUS
ePlus
2,19926.39 million25.88 millionOptionable

Recent News About These Companies

ePlus inc. (NASDAQ:PLUS) Short Interest Update
ePlus, Inc. Investigated by the Portnoy Law Firm
ePlus Named To Prestigious CRN Tech Elite 250 For 2026

Media Sentiment Over Time

Top Headlines

View All Headlines
Agraflora Organics International stock logo

Agraflora Organics International CNSX:AGRA

AgraFlora Organics International Inc. operates in the cannabis industry in Canada and the Republic of Colombia. The company was formerly known as PUF Ventures Inc. and changed its name to AgraFlora Organics International Inc. in November 2018. The company was incorporated in 2004 and is headquartered in Vancouver, Canada.

Abattis Bioceuticals CNSX:ATT

Abattis Bioceuticals Corp. is a specialty biotechnology company. The Company aggregates, incubates, integrates and invests in the natural health product and botanical drug development industry. It operates through the segment of producing, licensing and marketing ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The Company, through its subsidiaries, develops and commercializes natural health (nutraceutical) products, and conducts research and development to create plant-based (botanical) intellectual property and ingredients for the pharmaceutical and bioceutical markets, among others. It offers products and services, such as botanical blends and formulas; cannabidiol ingredients; functional foods and beverages, and analytical services. It is focused on creating botanical formulations, medical marijuana and specialized health products for pain caused by inflammation, and mental ailments.

Neuralstem stock logo

Neuralstem NASDAQ:CUR

Neuralstem, Inc., a clinical stage biopharmaceutical company, focuses on the research and development of nervous system therapies based on its proprietary human neuronal stem cells and small molecule compounds. The company's stem cell based technology enables the isolation and expansion of human neural stem cells from various areas of the developing human brain and spinal cord enabling the generation of physiologically relevant human neurons of various types. Its lead product candidate is NSI-189, a chemical entity, which has been completed Phase II clinical trial for the treatment of major depressive disorder, as well as is in preclinical study for the treatment-refractory depression, Angelman Syndrome, Alzheimer's disease, ischemic stroke, diabetic neuropathy, irradiation-induced cognitive deficit, and long-term potentiation enhancement. The company also develops NSI-566, which has completed Phase II clinical trial for treating amyotrophic lateral sclerosis disease; Phase II clinical trial for the treatment of chronic ischemic stroke; and Phase I clinical trials for the treatment of chronic spinal cord injury, as well as is in preclinical study for the traumatic brain injury. In addition, it develops NSI-532, which is in preclinical study for treatment of Alzheimer's disease; and NSI-777 that is in preclinical study for treatment of human demyelinating diseases. Neuralstem, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.

ePlus stock logo

ePlus NASDAQ:PLUS

$87.15 +1.56 (+1.82%)
Closing price 04:00 PM Eastern
Extended Trading
$89.34 +2.18 (+2.51%)
As of 07:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ePlus inc., together with its subsidiaries, provides information technology (IT) solutions that enable organizations to optimize their IT environment and supply chain processes in the United States and internationally. It operates through two segments, Technology and Financing. The Technology segment offers hardware, perpetual and subscription software, maintenance, software assurance, and internally provided and outsourced services; managed services or infrastructure and cloud; and enhanced maintenance support, service desk, storage-as-a-service, cloud hosted and managed, and managed security services; and professional, staff augmentation, cloud consulting, consulting, and security services. The Financing segment engages in financing arrangements, such as sales-type and operating leases; loans and consumption-based financing arrangements; and underwriting, management, and disposal of IT equipment and assets. Its financing operations comprise sales, pricing, credit, contracts, accounting, and risk and asset management. This segment primarily finances IT, communication-related, and medical equipment; and industrial machinery and equipment, office furniture and general office equipment, transportation equipment, and other general business equipment directly, as well as through vendors. The company serves commercial entities, state and local governments, government contractors, healthcare, and educational institutions. The company was formerly known as MLC Holdings, Inc. and changed its name to ePlus inc. in 1999. ePlus inc. was founded in 1990 and is headquartered in Herndon, Virginia.